U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. ECIG Online Ltd d/b/a Vvapour - 597052 - 11/02/2020
  1. Warning Letters

CLOSEOUT LETTER

ECIG Online Ltd d/b/a Vvapour MARCS-CMS 597052 —

Delivery Method:
VIA Electronic Mail
Reference #:
RW1901212
Recipient:
Recipient Name
Jonathan Matthew Hewston
ECIG Online Ltd d/b/a Vvapour

United States

info@vvapour.co.uk
inquiries@vvapour.co.uk
sales@vvapour.co.uk
Issuing Office:
Division of Promotion, Advertising, and Labeling

United States

Dear Jonathan Matthew Hewston:

The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your response, dated November 26, 2019, in response to our Warning Letter dated November 26, 2019. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://vvapour.co.uk.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.

Sincerely,
/S/
David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products

Back to Top